E

Enanta Pharmaceuticals
D

ENTA

8.84000
USD
0.28
(3.27%)
Market Closed
Volume
3,532
EPS
-5
Div Yield
-
P/E
-2
Market Cap
187,306,968
OverviewSignalsIdeasNews
Related Instruments
    A
    ALX
    0.900
    (0.42%)
    217.400 USD
    A
    APLS
    -1.750
    (-6.24%)
    26.280 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    A
    ASND
    2.160
    (1.74%)
    126.510 USD
    A
    AXSM
    -4.300
    (-4.41%)
    93.150 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    C
    CRVS
    -0.31000
    (-3.64%)
    8.21000 USD
    M
    MCRB
    -0.04240
    (-7.16%)
    0.54970 USD
    More
News

Title: Enanta Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Enanta Pharmaceuticals Inc is an American biotechnology company focused on the research and development of molecule drugs to cure viral infections and liver diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.